Low Brand Recognition Leaves Zicam Plenty Of Room To Grow
This article was originally published in The Tan Sheet
Zicam's relatively low brand name recognition represents significant growth potential for the line, Matrixx Initiatives asserted during a fourth-quarter and full-year 2005 earnings call Feb. 14
You may also be interested in...
Matrixx is concentrating research spending on antacids, analgesics and oral care as possible areas for new product development
Matrixx Initiatives will promote its Zicam and Nasal Comfort cough, cold and allergy products with an original multimedia marketing campaign in the second half of 2005
The global scope of food safety is becoming apparent, and recent problems with products imported from China are but a part of U.S. food safety concerns, industry experts say